Hostname: page-component-586b7cd67f-rdxmf Total loading time: 0 Render date: 2024-12-01T01:20:19.232Z Has data issue: false hasContentIssue false
  • English
  • Français

Control of Transmission of Vancomycin-Resistant Enterococcus faecium in a Long-Term–Care Facility

Published online by Cambridge University Press:  02 January 2015

Maxine Armstrong-Evans ,
Margaret Litt ,
Margaret A. McArthur ,
Barbara Willey ,
Darlene Cann ,
Susan Liska ,
Sidney Nusinowitz ,
Richard Gould ,
Anna Blacklock  and
Donald E. Low
...Show all authors
Maxine Armstrong-Evans
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
Margaret Litt
Affiliation:
Laboratory Centre for Disease Control, Health Canada, Ottawa, Ontario, Canada
Margaret A. McArthur
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
Barbara Willey
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
Darlene Cann
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
Susan Liska
Affiliation:
Barton Place Nursing Home, Toronto, Ontario, Canada
Sidney Nusinowitz
Affiliation:
Barton Place Nursing Home, Toronto, Ontario, Canada Department of Family Medicine, University of Toronto, Toronto, Ontario, Canada
Richard Gould
Affiliation:
City of Toronto Public Health Department, Toronto, Ontario, Canada
Anna Blacklock
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
Donald E. Low
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
Allison McGeer*
Affiliation:
Department of Microbiology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Ottawa, Ontario, Canada
*
Room 1460, Department of Microbiology, Mount Sinai Hospital, 600 University Ave, Toronto, Ontario, Canada M5G 1X5
Get access Rights & Permissions [Opens in a new window]

Abstract

Objectives:

To describe the investigation and control of transmission of vancomycin-resistant enterococci (VRE) in a residential long-term-care (LTC) setting.

Outbreak Investigation:

A strain of vancomycin-resistant Enterococcus faecium not previously isolated in Ontario colonized five residents of a 254-bed LTC facility in Toronto. The index case was identified when VRE was isolated from a urine culture taken after admission to a local hospital. Screening of rectal swabs from all 235 residents identified four others who were colonized with the same strain of E faecium.

Control Measures:

Colonized residents were cohorted. VRE precautions were established as follows: gown and gloves for resident contact, restriction of contact between colonized and noncolonized residents, no sharing of personal equipment, and daily double-cleaning of residents' rooms and wheelchairs.

Outcome:

Two colonized residents died of causes unrelated to VRE. Although bacitracin therapy (75,000 units four times a day X 14 days) failed to eradicate carriage in two of three surviving residents, both cleared their carriage within 7 weeks. Repeat rectal swabs from 224 residents (91%) 2 months after isolation precautions were discontinued and from 125 residents (51%) 9 months later identified no new cases. Total cost of investigation and control was $12,061 (Canadian).

Conclusion:

VRE may be transmitted in LTC facilities, and colonized LTC residents could become important VRE reservoirs. Control of VRE transmission in LTC facilities can be achieved even with limited resources.

Type
Orginal Articles
Information
Infection Control & Hospital Epidemiology , Volume 20 , Issue 5 , May 1999 , pp. 312 - 317
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1999

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Frieden, TR, Munsiff, SS, Low, DE, Willey, BM, Williams, G, Faur, Y, et al. Emergence of vancomycin-resistant enterococci in New York City. Lancet 1993;343:76–79.CrossRefGoogle Scholar
2. Livornese, LL Jr, Dias, S, Samel, C, Romanowski, B, Taylor, S, May, P, et al. Hospital-acquired infection with vancomycin-resistant E. faecium transmitted by electronic thermometers. Ann Intern Med 1992;117:112–116.Google Scholar
3. Karanfil, LV, Murphy, M, Josephson, A, Gaynes, R, Mandel, L, Hill, CC, et al. A cluster of vancomycin-resistant Enterococcus faecium in an intensive care unit. Infect Control Hosp Epidemiol 1992;13:195–200.CrossRefGoogle Scholar
4. Boyce, JM, Mermel, IA, Zervos, MJ, Rice, LB, Potter-Bynoe, G, Giorgio, C, et al. Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995;16:634–637.CrossRefGoogle ScholarPubMed
5. Weinstein, JW, Roe, M, Towns, M, Sanders, L, Thorpe, JJ, Corey, GR, et al. Resistant enterococci: a prospective study of prevalence, incidence and factors associated with colonization in a university hospital. Infect Control Hosp Epidemiol 1996;17:3641.CrossRefGoogle ScholarPubMed
6. Slaughter, S, Hayden, MK, Nathan, C, Hu, TC, Rice, T, Van Voorhis, J, et al. A comparison of the effect of universal use of gloves and gowns and that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996;125;450–456.Google Scholar
7. Flourney, DJ. Antimicrobial susceptibilities of bacteria from nursing home residents in Oklahoma. Gerontology 1994;40:53–66.Google Scholar
8. Bonilla, HF, Zervos, MA, Lyons, MJ, Bradley, SF, Hedderwick, SA, Ramsey, MA, et al. Colonization with vancomycin-resistant Enterococcus faecium: comparison of a long-term-care unit with an acute-care hospital. Infect Control Hosp Epidemiol 1997;18:333–339.Google Scholar
9. Ribeiro, J, Chenevert, C, Miller, N, Boyce, JM. Prevalence of vancomycin-resistant enterococci (VRE) among nursing home residents. Infect Control Hosp Epidemiol 1997;18(part 2):P23. Abstract 23.Google Scholar
10. Wenot, C, Krause, CH, Xander, L, Ruden, H. Prevalence of colonization with vancomycin resistant enterococci. Infect Control Hosp Epidemiol 1997;18(part 2):P23. Abstract 24.Google Scholar
11. Chenoweth, CE, Bradley, SF, Terpenning, MS, Zarins, LT, Ramsey, MA Schaberg, DR, et al. Colonization and transmission of high-level gentam-icin-resistant Enterococcus in a long-term care facility. Infect Control Hosp Epidemiol 1994;15:703–709.CrossRefGoogle ScholarPubMed
12. Zervos, MJ, Terpenning, MS, Schaberg, DR, Therasse, PM, Medendorp, SV, Kauffman, CA. High-level aminoglycoside-resistant enterococci colonization of nursing home and acute care hospital patients. Arch Intern Med 1987;147:1591–1594.Google Scholar
13. Patterson, EJ, Zervos, MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Clin Infect Dis 1990;12:644–652.Google Scholar
14. Strausbaugh, LT, Jacobson, C, Yost, T. Methicillin-resistant Staphylococcus aureus in a nursing home and affiliated hospital: a four-year perspective. Infect Control Hosp Epidemiol 1993;14:331–336.Google Scholar
15. Bradley, SF. Methicillin-resistant Staphylococcus aureus in nursing homes: epidemiology, prevention and management. Drugs and Aging 1997;10:185–198.Google Scholar
16. Linneman, CC Jr, Moore, P, Staneck, JL, Pfaller, MA. Reemergence of epidemic methicillin-resistant Staphylococcus aureus in a general hospital associated with changing staphylococcal strains. Am J Med 1991;91(3B):238S–244S.Google Scholar
17. Fraise, AP, Mitchell, K, O'Brien, SJ, Oldfield, K, Wise, R. Methicillin-resistant Staphylococcus aureus in nursing homes in a major UK city: an anonymized point prevalence survey. Epidemiol Infect 1997;118:1–5.Google Scholar
18. Centers for Disease Control and Prevention. Recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for preventing the spread of vancomycin resistance. MMWR 1995;44(RR-12):1–13.Google Scholar
19. Boyce, JM. Vancomycin-resistant enterococci: pervasive and persistent pathogen. Infect Control Hosp Epidemiol 1995;16:676–679.CrossRefGoogle Scholar
20. Ontario Nursing Home Association. Guidelines for the Management of Residents with Vancomycin Resistant Enterococci in Long Term Care Facilities. Markham, Ontario, Canada: Ontario Nursing Home Association; 1996.Google Scholar
21. Landman, D, Quale, JM, Oydna, E, Willey, B, Ditore, V, Zaman, M, et al. Comparison of five selective media for identifying fecal carriage of vancomycin resistant enterococci. J Clin Microbiol 1996;34:751–752.Google Scholar
22. Willey, BM, Kreiswirth, BN, Simor, AE, Williams, G, Scriver, SR, Phillips, A, et al. Detection of vancomycin resistance in Enterococcus species. J Clin Microbiol 1992;30:1621–1624.Google Scholar
23. Willey, BM, Marshall, W, Mazzulli, T, Lo, P, Mustachi, C, Gill, A, et al. Evaluation of methods for the detection of enterococcal motility. Presented at the 96th General Meeting of the American Society for Microbiology; May 1996; New Orleans, LA Abstract C-378.Google Scholar
24. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobkally. 4th ed. NCCLS Document M7-A4. Approved standard. Wayne, PA NCCLS; 1997.Google Scholar
25. Murray, BE, Singh, KV, Heath, JK, Sharma, BR, Weinstock, GM. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990;28:2059–2063.Google Scholar
26. Miele, A Bandera, M, Goldstein, BR Use of primers selective for vancomycin resistance genes to determine van genotype in enterococci and to study gene organization in vanA isolates. Antimicrob Agents Chemother 1995;39:1772–1778.Google Scholar
27. Humar, A, Dedier, I, Campbell, I, Brunton, J, Willey, B, Low, D, et al. Clinical and microbiological analysis of a vancomycin-resistant Enterococcus outbreak in a dialysis population. Presented at the 36th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1996; New Orleans, LA Abstract J3.Google Scholar
28. Berntson, A Green, K, Willey, B, Fleming, CA Blacklock, A, Richardson, H, et al. Emergence of vancomycin-resistant enterococci in Ontario. Presented at the 37th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 28-October 1, 1997; Toronto, Ontario, Canada. Abstract C-154.Google Scholar
29. Willey, BM, Blacklock, A Ontario, VRE Surveillance Study, McGeer, A Low, DE. Molecular epidemiology of the emergence of vancomycin-resistant enterococci in Ontario, Canada. Presented at the 36th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy; September 15-18,1996; New Orleans, LA Abstract C16.Google Scholar
30. Boyce, JM, Opal, SM, Chow, JW, et al. Outbreak of multidrug resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol 1994;22:1148–1153.Google Scholar
31. Moreno, F, Grota, P, Crisp, C, Magnon, K, Melcher, GP, Jorgensen, JH, et al. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis 1995;21:1234–1237.CrossRefGoogle Scholar
32. Pegues, DA Pegues, C, Hibberd, B, Ford, D, Hooper, D. Emergence and dissemination of a highly-vancomycin resistant vanA strain of Enterococcus faecium at a large teaching hospital. J Clin Microbiol 1997;35:1565–1570.Google Scholar
33. New York State Department of Health. Supplemental Infection Control Guidelines for the Care of Patients Colonized or Infected With Vancomycin-Resistant Enterococci in Hospitals, Long Term Care Facilities, and Home Health Care. Health Facilities Series 95-14. State of New York Department of Health memorandum. Albany, NY: NYS Dept of Health; 1995.Google Scholar
34. Chia, JKS, Nakata, MM, Parks, SS, Lewis, RP, McKee, B. Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium . Clin Infect Dis 1995;21:1520.Google Scholar
35. McGeer, A Cann, D, Mustachi, B, Willey, B, Wigston, C, Low, DE. Evaluation of oral bacitracin therapy for the eradication of colonization of resistant enterococci. Presented at the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 1995; San Francisco, CA Abstract J142.Google Scholar
36. O'Donovan, CA Fan-Havard, P, Tecson-Tumang, FT, Smith, SM, Eng, RHK. Enteric eradication of vancomycin-resistant Enterococcus faecium with oral bacitracin. Diagn Microbiol Infect Dis 1994;18:105–109.CrossRefGoogle ScholarPubMed
37. Montecalvo, MA, deLancastre, H, Carraher, M, Gedris, C, Chung, M, Van Horn, K, et al. Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 1995;16:680–685.Google Scholar
38. Green, M, Barbadora, H, Michaels, M. Recovery of vancomycin-resistant gram positive cocci from pediatric liver transplant patients. J Clin Microbiol 1991;29:2503–2506.Google Scholar